Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Artificial Intelligence

Algorae Pharmaceuticals Limited (ASX:1AI): Drug Combination Modelling and Pharmaceutical Development

The AlgoraeOS platform is used to model possible interactions between pharmaceutical compounds. Such computational results are candidates for laboratory evaluation, not proof that combinations will produce clinical benefit. The work described by Algorae Pharmaceuticals Limited (ASX:1AI) should be assessed against the specific product or …

Aditi Sarkar | 16 October 2026

Clever Culture Systems Limited (ASX:CC5): AI-Based Microbiology Automation and Pharmaceutical Testing

Clever Culture Systems Limited (ASX:CC5) addresses ai-based microbiology automation and pharmaceutical testing through its existing business activities. Image analysis can assist laboratory personnel in reading culture plates, but performance must be assessed for the specific specimen types and workflows in which a system is …

Aditi Sarkar | 16 October 2026

BrainChip Holdings (ASX:BRN): Sequora Processor IP Enters Commercial Licensing

Sequora is an intellectual property core, not a finished semiconductor product. Customers can license the design for incorporation into their own system-on-chip products. BrainChip Holdings (ASX:BRN) says the offering includes accompanying software and development tools, without providing detailed specifications of that suite.

Aditi Sarkar | 15 October 2026

Arbitr Group Limited (ASX:AGT): Enterprise AI Strategy, Quotation Reinstatement and 2026 Developments

Effective 29 September 2026, Straker Limited changed its name to Arbitr Group Limited, with its ASX security code changing to AGT. According to the company, the new identity reflects the Arbitr enterprise platform and a shift towards managing the context and controls needed when …

Aditi Sarkar | 15 October 2026

Hiremii Limited (ASX:HMI): AI Recruitment Technology and Workforce Operations

Hiremii (ASX:HMI) describes a recruitment system built around its knowledge-graph technology and specialised job descriptions. The product is designed to help interpret applicants’ experience and match candidates against technical requirements. Commercial outcomes depend on adoption and the quality of deployment rather than the capabilities …

Aditi Sarkar | 15 October 2026

Arbitr Group (ASX:AGT) Targets Enterprise AI Content Governance Amid Competitive Pressure and Corporate Restructuring Challenges

Arbitr Group Limited (ASX:AGT) operates in a market where the global localization and translation industry has experienced structural transformation due to the rapid advancement of large language models and neural machine translation.

Aditi Sarkar | 14 October 2026

Algorae Pharmaceuticals (ASX:1AI): AI Drug Discovery and 2026 Commercial Developments

AlgoraeOS analyses biological and pharmacological information to identify combinations that may warrant laboratory investigation. Unlike a completed clinical study, computational screening produces hypotheses; experimental testing is needed to establish whether predicted interactions occur in biological systems. This distinction matters when assessing the reported development …

Aditi Sarkar | 14 October 2026

Clever Culture Systems Limited (ASX:CC5): How AI Culture Plate Screening Supports Pharmaceutical Laboratory Automation

The APAS Independence system is designed to evaluate culture plates that laboratories use to detect microbial growth. Automated imaging and software assessment can help standardise an otherwise labour-intensive screening process. The applications differ between pharmaceutical environmental monitoring and clinical diagnostic laboratories, so evidence from …

Aditi Sarkar | 14 October 2026

How SEEK Limited (ASX:SEK) Uses AI to Improve Candidate and Job Matching

Employment searches require systems to interpret information that is often expressed in different ways. Job advertisements may specify responsibilities, qualifications, seniority or location, while candidate profiles describe skills, experience and preferences using varied terminology. SEEK (ASX:SEK) applies data and AI capabilities to help connect …

Aditi Sarkar | 13 October 2026

BrainChip Holdings Limited (ASX:BRN): How Akida Edge AI Licensing Is Progressing

The Akida processor architecture is designed to analyse patterns in sensor data, including visual, audio and industrial signals. Event-based processing can reduce unnecessary computation in applications where input conditions change intermittently. BrainChip Holdings Limited (ASX:BRN) offers hardware, development software and semiconductor intellectual property to …

Aditi Sarkar | 13 October 2026
Support

Hi! How can we help you today?

Loading…